The Evidence Speaks (April 2022)
This edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read MoreMarch 8, 2022
This edition highlights research evaluating patient involvement in clinical trial design, detecting prior COVID-19 infections, and the effect of wildfires on respiratory health
Read More
The growing body of research on women’s heart health has revealed a significant gap in cardiac care, stimulating advocacy, clinical trials, and changes in practice to improve the lives of women living with heart disease
Read More
CHÉOS' Dr. Habib Chaudhury is passionate about making supportive, meaningful, physical environments for people living with dementia
Read More
Study highlights the importance of opioid agonist therapy during the overdose crisis, including the need to support continued treatment
Read More
CHÉOS Scientists Drs. Skye Barbic and Frank Scheuermeyer are teaming up to improve the integration between emergency departments and mental health services for youth and young adults.
Read More
Canada is the first country to approve the pain drug for severe opioid use disorder, a result of research led by CHÉOS and PHC scientists and staff.
Read More